Consulting

Overview

Knowing where to begin or where to go can make all the difference in the world when planning or revising your compound development program. Whether it's guidance about the FDA's perspective or explaining results from a study to plan your next move, we can help. Our consulting team, led by Brian Ogilvie, Ph.D., has a strong history of experience and unsurpassed expertise regarding metabolism-related issues. Invest your time and money wisely; let Sekisui XenoTech consulting guide you in the right direction for all of your drug development needs!

Sekisui XenoTech Consulting can help navigate your compound development with the following services:
  • Review all study-related data conducted at Sekisui XenoTech
  • Recommend additional studies necessary to satisfy an IND submission
  • Provide advice on the interpretation of preclinical metabolism data (e.g., CYP inhibition, induction or clearance) with a special emphasis on in vitro-in vivo extrapolation (IVIVE) and an evaluation of the victim and perpetrator potential of a drug candidate
  • Prepare expert opinion papers on ADME-Tox issues
  • Review or prepare material for Investigator's Brochures
  • Prepare responses to questions from the FDA and other regulatory agencies
  • Deliver lectures on special topics, including basic courses on drug metabolism
  Find the Services You Need  
How Can We Help You?
Or Call 1-877-588-7530
(+1.913.438.7450 If Outside North America)
Contact Us

Contact Us

Questions or inquiries? Use our contact form and we’ll reply as soon as possible.* indicates required field

Request A Quote
Request A Quote

Request A Quote

 Security code